Literature DB >> 3136192

The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.

B A Konkle1, D Ginsburg.   

Abstract

Plasminogen activator inhibitor-1 (PAI-1) is a specific and rapid inhibitor of tissue plasminogen activator (tPA) and urokinase. Clinical studies suggest that PAI-1 may play a crucial role in the regulation of fibrinolysis. A number of factors modulate PAI-1 activity in endothelial cell culture, and the isolation of PAI-1 cDNA now allows study of PAI-1 regulation at the mRNA level. We examined the effect of endothelial cell growth factor (ECGF) and heparin on PAI-1 expression in human umbilical vein endothelial cell (HUVEC) culture. The addition of ECGF and heparin to HUVEC cultures results in a 3-10-fold decrease in the PAI-1 activity secreted into the conditioned media. This effect is mediated at the mRNA level. A decrease in PAI-1 is also seen with higher concentrations of ECGF alone, but is greatly enhanced by the addition of heparin. No significant change in tPA antigen or mRNA levels was observed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136192      PMCID: PMC303551          DOI: 10.1172/JCI113635

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

Review 1.  Culture of vascular endothelium.

Authors:  M A Gimbrone
Journal:  Prog Hemost Thromb       Date:  1976

2.  Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238).

Authors:  M L Larsen; U Abildgaard; A N Teien; K Gjesdal
Journal:  Thromb Res       Date:  1978-08       Impact factor: 3.944

3.  Isolation and DNA sequence of a full-length cDNA clone for human X chromosome-encoded phosphoglycerate kinase.

Authors:  A M Michelson; A F Markham; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

4.  Initiation and regulation of fibrinolysis in human plasma at the plasminogen activator level.

Authors:  T C Wun; A Capuano
Journal:  Blood       Date:  1987-05       Impact factor: 22.113

5.  Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.

Authors:  I Juhan-Vague; J Valadier; M C Alessi; M F Aillaud; J Ansaldi; C Philip-Joet; P Holvoet; A Serradimigni; D Collen
Journal:  Thromb Haemost       Date:  1987-02-03       Impact factor: 5.249

6.  Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis.

Authors:  H M Chiu; J Hirsh; W L Yung; E Regoeczi; M Gent
Journal:  Blood       Date:  1977-02       Impact factor: 22.113

7.  Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis.

Authors:  E G Vairel; H Bouty-Boye; F Toulemonde; C Doutremepuich; N A Marsh; P J Gaffney
Journal:  Thromb Res       Date:  1983-05-01       Impact factor: 3.944

8.  Pregnancy-induced changes in the fibrinolytic balance: evidence for defective release of tissue plasminogen activator and increased levels of the fast-acting tissue plasminogen activator inhibitor.

Authors:  M Gore; S Eldon; K F Trofatter; S J Soong; S V Pizzo
Journal:  Am J Obstet Gynecol       Date:  1987-03       Impact factor: 8.661

9.  The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor.

Authors:  S L Hersch; T Kunelis; R B Francis
Journal:  Blood       Date:  1987-05       Impact factor: 22.113

10.  Serial propagation of human endothelial cells in vitro.

Authors:  T Maciag; G A Hoover; M B Stemerman; R Weinstein
Journal:  J Cell Biol       Date:  1981-11       Impact factor: 10.539

View more
  11 in total

1.  IL-1-induced procoagulant and fibrinolytic activities of human endothelium grown on carbodiimide crosslinked proteins.

Authors:  R Warocquier-Clérout; J Penhoat; M F Sigot-Luizard
Journal:  Cytotechnology       Date:  1991-11       Impact factor: 2.058

2.  Shear stress-mediated changes in the expression of leukocyte adhesion receptors on human umbilical vein endothelial cells in vitro.

Authors:  R Sampath; G L Kukielka; C W Smith; S G Eskin; L V McIntire
Journal:  Ann Biomed Eng       Date:  1995 May-Jun       Impact factor: 3.934

3.  The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain.

Authors:  K A Cooney; W C Nichols; M E Bruck; W F Bahou; A D Shapiro; E J Bowie; H R Gralnick; D Ginsburg
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Complementary DNA cloning of the alternatively expressed endothelial cell glycoprotein Ib beta (GPIb beta) and localization of the GPIb beta gene to chromosome 22.

Authors:  M D Kelly; D W Essex; S S Shapiro; F J Meloni; T Druck; K Huebner; B A Konkle
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

5.  Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets.

Authors:  K A Cooney; S E Lyons; D Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

6.  Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin.

Authors:  G Melandri; A Branzi; F Semprini; V Cervi; N Galiè; B Magnani
Journal:  Br Heart J       Date:  1990-08

7.  Acidic fibroblast growth factor promotes vascular repair.

Authors:  T D Bjornsson; M Dryjski; J Tluczek; R Mennie; J Ronan; T N Mellin; K A Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  Improving the Efficacy and Stability of Coronary Reperfusion Following Thrombolysis: Exploring the Thrombin Hypothesis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

9.  Cultivation of human dermal microvascular endothelial cells in vitro: immunocytochemical and ultrastructural characterization and effect of treatment with three synthetic retinoids.

Authors:  E Imcke; Z Ruszczak; A Mayer-da Silva; M Detmar; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

10.  Intermittent Hypoxia Activates Duration-Dependent Protective and Injurious Mechanisms in Mouse Lung Endothelial Cells.

Authors:  Peter Wohlrab; Lourdes Soto-Gonzales; Thomas Benesch; Max Paul Winter; Irene Marthe Lang; Klaus Markstaller; Verena Tretter; Klaus Ulrich Klein
Journal:  Front Physiol       Date:  2018-12-06       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.